/

Investors / Sirona Capital

Sirona Capital

Venture capital

sironacap.com

Sirona Capital is a healthcare venture capital fund that invests in healthcare innovation and therapeutics. It supports startups and early-stage companies in medical technology and biopharmaceuticals, offering strategic guidance and access to an industry network.

Invests inHealthcare & Biotech

In its own wordshealthcarelife sciencesbiopharmaceuticalsmedical technologytherapeutics

Your fit with Sirona Capital

Four questions about your startup

See how your round matches what it backs, point by point.

Or find every investor that fits
8portfolio companies
0funding rounds on record
Seed to Series Astages it states

Sirona Capital lists 8 checked portfolio companies on its own site. Its largest themes are Healthcare & Biotech (88%) and Industrial & Manufacturing (13%). 83% of its companies are based in United States. It invests most often alongside Catalio Capital Management, Foresite Capital and RA Capital.

No funding round on record names Sirona Capital yet, so the figures come from its portfolio page.

Investor profile

percentile among all firms
Portfolio size: 8 companiesRecent activity: 0 rounds in 12 monthsEarly stage: 0% of entries at pre-seed or seedEvidence: 0% of companies confirmed by a roundSector focus: 88% in its largest sectorReach: 2 countriesPortfolio size15th pctRecent activity46th pctEarly stage54th pctEvidence52th pctSector focus95th pctReach42th pct
This firmMedian of all firms
Show as a table
Sirona Capital compared with all firms
MeasurePercentile of all firmsValue
Portfolio size15th8 companies
Recent activity46th0 rounds in 12 months
Early stage54th0% of entries at pre-seed or seed
Evidence52th0% of companies confirmed by a round
Sector focus95th88% in its largest sector
Reach42th2 countries

Its portfolio companies

where they are based, and what their own sites show

Headquarters

Site status

  • Site answers8100%
  • No longer answers00%
  • Points to another company00%
  • Parked or sold domain00%

A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.

Investment themes

share of its checked companies

This firmAll checked companies

Show as a table
Investment themes
This firmAll checked companies
Healthcare & Biotech88%15%
Industrial & Manufacturing13%7%

Co-investor network

who it backs companies with, and who they back together
22 shared companies11 shared companies10 shared companies7 shared companies7 shared companies6 shared companies5 shared companies5 shared companies5 shared companies5 shared companies4 shared companies3 shared companies3 shared companies3 shared companies3 shared companies3 shared companies3 shared companies2 shared companies2 shared companies2 shared companies2 shared companies2 shared companies2 shared companies2 shared companiesCatalio Capital Management: 2 shared companiesCatalio Capital Manag…2Foresite Capital: 2 shared companiesForesite Capital2RA Capital: 2 shared companiesRA Capital25AM Ventures: 1 shared companies5AM Ventures1Ascenta Capital: 1 shared companiesAscenta Capital1Atlas Venture: 1 shared companiesAtlas Venture1Camford Capital: 1 shared companiesCamford Capital1Canaan: 1 shared companiesCanaan1Connecticut Innovations: 1 shared companiesConnecticut Innovatio…1Decheng Capital: 1 shared companiesDecheng Capital1Elm Street Ventures: 1 shared companiesElm Street Ventures1General Atlantic: 1 shared companiesGeneral Atlantic1
Shared portfolio companies with Sirona CapitalFirms that also back companies together

All co-investors or Compare portfolios with Catalio Capital Management

Compare Sirona Capital head to head

portfolio size, rounds, entry stages, themes and the companies both back

Three or more firms at once: portfolio overlap.

Portfolio

8 companies checked against their own sites
CompanyWhat it doesThemesFirst round with itEvidence
Adarxadarx.com · United StatesAdarx Pharmaceuticals is developing next-generation siRNA therapeutics to treat various diseases.
Healthcare & Biotech
Portfolio page
ArriVentarrivent.com · United StatesThe company is dedicated to the identification, development and commercialization of differentiated medicines to address the unmet medical needs of patients with difficult-to-treat diseases, beginning with cancers.
Healthcare & Biotech
Portfolio page
Arvinasarvinas.comArvinas develops targeted protein degradation therapeutics for serious diseases, particularly in neurology and oncology.
Healthcare & Biotech
Portfolio page
Avereaveretx.com · United StatesAvere Therapeutics is developing an oral, once-weekly interleukin-23 receptor antagonist designed to treat inflammatory disease.
Healthcare & Biotech
Portfolio page
CG Oncologycgoncology.comCG Oncology develops and delivers bladder-sparing immunotherapies for bladder cancer
Healthcare & Biotech
Portfolio page
Kailerakailera.com · United StatesKailera is developing therapies for obesity to give people the power to restore their health and transform their lives.
Healthcare & Biotech
Portfolio page
OTR Therapeuticsotr-tx.com · ChinaOTR Therapeutics discovers and acquires distinctive preclinical assets and accelerates them into clinical therapies.
Healthcare & Biotech
Portfolio page
Synnovationsynnovation.com · United StatesSynnovation LLC develops and manufactures products using industrial 3D printing technology
Industrial & Manufacturing
Portfolio page

About this data

site last read 5 Nov 2026
The homepage of Sirona Capital, as last read
sironacap.com as VCinfo last read it
Site
sironacap.com
Last read
5 Nov 2026
Watching since
6 Nov 2026
Companies checked
8

Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.

How we grade the data

Free account · no card

Get Sirona Capital's profile as data

Pull Sirona Capital's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.

Work email, sign-in link by email. Already have an account? Log in
  • Ask AI5 plain-English investor searches a day
  • Full listsEvery portfolio row and two-firm overlap
  • API and MCP100 REST or MCP calls a month, one key
  • AlertsFollow 5 investors for portfolio and fund changes
VCinfo API
$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/firms/sironacap.com

# also
GET /v1/firms/sironacap.com/portfolio
GET /v1/firms/sironacap.com/coinvestors
GET /v1/firms/sironacap.com/news
The same data as an MCP server for Claude, Cursor and other AI tools. Set up MCP · Docs · Pricing